Li Wei

A randomized phase I clinical trial comparing the pharmacokinetic, safety, and immunogenicity of potential biosimilar recombinant human HER2 monoclonal antibody for injection and trastuzumab in healthy Chinese adults

Haifeng Song, Q. Wang, Xiao-yan Nie, 2020, Expert opinion on investigational drugs.

On Some Aspects of Conditional Power Evaluation In Two-phase Clinical Trials Under Linear Regression

A. Hedayat, B. Sinha, Li Wei, 2012 .